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ABSTRACT
Disparity in access to health care and preventive services places a heavier burden of
morbidity on those with limited access and resources. Underserved populations with
decreased access to appropriate health screening and therapeutic interventions often
present with increased risks for peripheral arterial disease. Some patients with peripheral
arterial disease are asymptomatic and may defer treatment while others present with
occlusive disease requiring immediate therapy. Delaying diagnosis and treatment reduces
quality of life and functional status. The prevalence of peripheral arterial disease has been
extensively studied in the elderly population but the prevalence in the high-risk
underserved population is unknown. The purpose of this study was to identify the
prevalence of peripheral arterial disease in an underserved, high-risk, predominantly
African American population and to determine if providers using an electronic blood
pressure machine could accurately measure the ankle-brachial index. The sample
population of forty adult residents at a homeless shelter in northeast Florida was screened
for peripheral arterial disease. Inclusion criteria consisted of a diagnosis of hypertension,
hyperlipidemia, diabetes or a history of smoking. The ankle-brachial index was assessed
using the vascular Doppler method and an electronic blood pressure machine though the
latter was found to be an insensitive screening tool. The ankle-brachial index, the San
Diego Claudication Questionnaire and a physical assessment were used in this crosssectional study to determine the prevalence of peripheral arterial disease. An abnormal
ankle-brachial index value (:S 0. 90), indicating a high suspicion of peripheral arterial
disease, was assessed in 22.5% ofthe sample population, all of whom were found to have
a history of smoking crack cocaine.
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CHAPTER ONE
INTRODUCTION
Peripheral arterial disease (PAD) is significant, largely undiagnosed and
undertreated in primary care practice (Treat-Jacobson & Walsh, 2003). High-risk
underserved populations, with limited access to appropriate health screenings or
therapeutic interventions often present with multiple complications that contribute to
PAD, a manifestation of systemic atherosclerosis. Most patients with PAD are
asymptomatic but their risk of cardiovascular events and death is equal to that of patients
with symptomatic disease (Khunti, 2003).
The diagnosis and treatment of this disease poses challenges as most health care
providers' link atherosclerosis with heart disease and not necessarily PAD. Primary care
providers can readily identify the classic presentation of acute myocardial infarction
(AMI) and linlc the problem with coronary artery disease. Most are able to explain the
pathophysiology of the disease as an inflammatory process leading to atherosclerotic
deposits narrowing coronary arteries. Total myocardial arterial occlusion may ensue
causing tissue necrosis leading to significant morbidity and mortality. Prevention and
detection of heart disease and its risks are commonplace. Yet, how many could recognize
that a patient presenting with classic signs and symptoms of AMI may also have
peripheral arterial disease?
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Diehm et al. (2004) acknowledge that PAD prevalence data in primary care is
limited despite its vital impotiance to improve treatment outcomes. Experts call for the
development of enhanced PAD screening strategies to reduce the risks of cardiovascular
and cerebrovascular events in the community.
PAD is a progressive occlusion of the arteries supplying the peripheral
vasculature (Bordeaux, Reish, & Hirsch, 2003; Schainfeld, 2001). The carotid, abdominal
and lower extremity arteries are commonly affected by this disease. Stiihlinger and Tsao
(2003) describe PAD as a process whereby the affected vessel lumen narrows or becomes
obstructed impeding normal metabolic processes ultimately leading to significant
peripheral arterial occlusion. The pathogenesis of PAD is atherosclerosis, the same
disease that causes narrowing of coronary arteries leading to acute myocardial infarction.
This study addresses the significant problem oflower extremity PAD and its
impact on a high risk, underserved, predominantly homeless African American
population residing in a north east Florida homeless shelter. The important role of
primary care providers, particularly the role of the primary care nurse practitioner in
identifying PAD by screening for the disease using the ankle brachial index (ABI) is
delineated.

Background
Sources vary but most report that 8-12 million Americans are affected by PAD
(Lesho, Manngold & Gey, 2004; Hirsch, Criqui, Treat-Jacobson, Regensteiner, et.al,
2001). Prevalence data for PAD is equal for men and women and ranges from 12- 20%
according to the American Heart Association (n.d.) however Hirsch et al. reported a
prevalence of29% (2001) in a sample population with an average age over 70 years.
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Based on data from the National Health and Nutrition Examination Survey 1999-2000,
the prevalence among U.S. residents 2:40 years was 4.3% or approximately 5 million
people (Selvin & Edinger, 2004). Age is a major risk factor, as is the presence of diabetes
mellitus and smoking. Other important risk factors include poorly controlled
hypertension, hyperlipidemia, C-reactive protein and hyperhomocysteinemia (Schainfeld,
2001).
More than 20% of those with PAD experience walking induced intermittent
claudication in the lower back, buttock, hip, thigh, calf or foot arch of one or both legs
that diminishes with rest (Comerota, 2003). Intermittent claudication is pain that can be
described as cramping, burning or aching and may cause numbness (Meru, Mittra,
Thyagarajan & Chugh, in press). The severity may increase over time and the disease
progressively blocks blood flow in the affected extremity. Collateral circulation may
ensue effectively bypassing the narrowed artery limiting symptoms in some individuals
3with PAD. In others, the severity of PAD slowly increases causing limitations and up to
4% of those with the disease may require amputation (Sheehan, et al., 2003). Conducting
a history and physical exam helps the provider diagnose symptomatic PAD. History of
cigarette smoking, diabetes, hypertension and hyperlipidemia raise suspicion for the
disease. Differential diagnoses include spinal stenosis, lumbar disk disease, diabetic
neuropathy and arterial embolism.
Obtaining an ankle-to-arm ratio of systolic blood pressure using a standard blood
pressure cuff and a hand held Doppler device is a useful screening tool for PAD (Hirsch,
Gloviczki, Drooz, Lovell & Creager, 2004; Leng, Fowkes, Lee & Dunbar, et al.1996;
Sheehan et al., 2003). Those with abnormal screening ratios for PAD are referred to
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specialists for further workup, diagnosis and treatment. Specialists rule out other causes
of pain through careful questioning and physical examination. Diagnosis of PAD is often
done by an interventional radiologist who performs a catheterization and injects contrast
material into the abnormal blood vessels. Radiographs by digital subtraction angiography
or a video are obtained. Areas of vascular stenosis are reviewed in conjunction with
history and physical findings.
Stenotic vessels should be initially managed with exercise training and risk factor
modification but can also be treated pharmacologically (Lesho, Manngold & Gey 2004)
or by a variety oftechniques including balloon angioplasty, stents, bypass surgery, and
grafts (Seiggreen & Kline, 2004). Medical management often includes antiplatelet
therapy, medications that decrease vascular viscosity/ promote vessel flexibility and
anticoagulants.

Role ofHealth Care Providers
Physicians, nurse practitioners, registered nurses and other medical and nursing
staff are responsible for detecting those at risk for PAD. Primary care providers, such as
family physicians and family nurse practitioners play a critical role in the screening and
diagnosis of PAD. Experienced nurses, specifically trained in Doppler ultrasound
assessment can incorporate this vital procedure into routine evaluation of patients at risk
for atherosclerosis and PAD. A high index of suspicion is needed in this setting as nearly
70% of the patients are asymptomatic. Khunti (2003) suggests that screening should be
targeted to smokers and persons with hypertension, diabetes, and hypercholesterolemia.
The National Heart Lung and Blood Institute workshop also identified elevated
fibrinogen, hyperhomocysteinemia and increased C-reactive protein as PAD risk factors
(2003). In underserved populations, these known risks for cardiovascular disease and
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PAD often go undetected and untreated (Politzer, Schempf, Starfield, & Shi, 2003),
progressively damaging the vasculature.
It is important that all involved in detection of PAD know that the ABI may be

falsely elevated, especially in long-term diabetics and may signify non-compressible
arteries due to calcification (Fahey, 1999; Sheehan et al, 2003). Accuracy of results may
be limited in renal failure, obesity, systolic heart failure and vascular calcification.
Therefore, the diagnosis of PAD may be missed. Annual ABI measurements may aid
prognosis, particularly in patients without classic symptoms due to peripheral neuropathy
(Wasserman, 2001). According to Ouriel (2001), Doppler ankle-brachial index screening
should be routinely incorporated into the diagnostic workup when evaluating patients at
risk for atherosclerosis. Aggressive management of modifiable risk factors and
antiplatelet therapy are secondary and tertiary prevention strategies for PAD patients
(Hiatt, 2001).
Problem
The National Heart Lung and Blood Institute (NHLBI) (2003) identified PAD as a
significant health problem that is under-recognized. There are many barriers to diagnosis
of PAD including a lack of familiarity with typical symptoms, restriction of time spent
with patients in the primary care setting, inability to perform screening measures and
limited referrals to specialists. The ABI is a quantitative assessment of the severity of
PAD in nearly all affected individuals, whether or not they are symptomatic (Goodal,
2000). Although obtaining an ABI is non-invasive, inexpensive and well-tolerated (De
Sanctis, 2001), many primary care providers do not perform the test themselves nor do
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they refer patients for screening resulting in the problem of under-diagnosis and undertreatment.
Screening for PAD in underserved or homeless populations is more difficult to
accomplish because these individuals may not seek care. Additionally, providers may not
think about PAD screening when a homeless patient presents for another problem.
Primary care providers need to be aware of the asymptomatic nature of PAD in the
underserved in general and have a high index of suspicion for the disease. Identifying
those with known risk factors for cardiovascular disease is paramount in this population
(Politzer, Schempf, Starfield, & Shi, 2003).

Purpose & Research Questions
The purpose of this cross-sectional, descriptive study was twofold. The first goal
was to determine the prevalence of PAD in a high-risk, underserved, predominantly
African American, homeless population. The second goal was to determine if the
electronic blood pressure (oscillometric) machine (EBM) could accurately measure ABI
compared to findings obtained by Doppler technique.
Two research questions were addressed in this study. The first asked "What is the
prevalence of peripheral arterial disease in the target population" and the second asked
"What is the efficacy of using an EBM versus a Doppler for ABI screening?" Efficacy in
this setting means the ability of the EBM to obtain the same result as the Doppler for
ABI.

Variables
The antecedent variables were the participant's gender, pre-existing disease
status, ethnicity, physical assessment, claudication questionnaire results and smoking
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status. The predictor variables were age, blood pressure, fasting blood glucose,
glycosylated hemoglobin level (HgbAlc), total cholesterol, low-density lipoprotein level
(LDL), pack-year history and ABI. The ABI ratio is the criterion variable for which the
first research question is based. The following theoretical and operational definitions
were used.

Diabetes. Diabetes mellitus (DM) is any of a variety of abnormal conditions
characterized by inadequate secretion or inefficient utilization of insulin, over-production
of urine, excess glucose found in blood or urine and insatiable thirst. DM is a disorder of
carbohydrate metabolism due to heredity or environmental factors (Pease, 2002). In this
study, previously documented DM operationally confirmed presence of the disease and
level of diabetic control was measured by fasting blood glucose and HgbA 1C.

Hypertension. Hypertension is arterial blood pressure that is abnormally high. For the
purpose of this study, prehypertension, stage 1 hypertension and stage 2 hypertension
based on the Seventh Report of the Joint National Committee (JNC 7) will categorically
define hypertension. Patients with a systolic pressure of 120-139 mmHg or a diastolic
pressure of 80-89 mmHg are considered pre-hypertensive. Stage 1 hypertension is
indicated by a systolic of 140-159 mmHg or a diastolic of90-99 mmHg and Stage 2 by a
systolic ?:160 mmHg and a diastolic ?:100 mmHg. (U.S. Department of Health and
Human Services, 2004). The ADA suggests that diagnosed diabetics control BP to
<130/80 (Saydah, Fradkin, & Cowie, 2004). In this study, previously documented
hypertension operationally confirmed presence of the disease and blood pressure control
was measured by resting blood pressure at the time of data collection.
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Hypercholesterolemia. Hypercholesterolemia is a condition in which excess lipids are
found in the blood. For the purpose of this study a total cholesterol of>200mg/dL and/or
LDL levels> 1OOmg/dL constitute the operational definition of hyperlipidemia.
Hyperlipidemia is also known as dyslipidemia and hypercholesterolemia in the literature.

Smoker. A smoker is defined as a person who smokes tobacco or crack cocaine
habitually. A documentation of crack cocaine smoking is also noted if provided by the
resident. Residents in the sample population are not permitted to smoke while in the
program; therefore, as the study commenced, those identified as smokers were not
smoking at the time. The operational definition of smoker was any patient who
previously identified him or herself as such. A pack year history or years of cigarette or
crack use was recorded if provided by the patiicipant.

Ankle-brachial index. An ankle-brachial index is the ratio that is obtained by establishing
the systolic blood pressure in each ankle and dividing it by the highest brachial systolic
pressure (Leng, Fowkes, Lee, Dunbar, & et al, 1996). For the purpose of this study, a
patient was classified as having PAD if they had an ABI:S0.90 (Hirsch et al., 2001; Leng,
1996). Two techniques, the gold standard, hand-held vascular Doppler and an electronic
blood pressure machine (EBM), were used to evaluate ABI for this study.

Peripheral arterial disease. PAD is a condition in which progressive occlusion of blood
vessels occur, particularly in the extremities. PAD has also been expressed as peripheral
arterial occlusive disease (PAOD), lower extremity occlusive disease (LEAD) and
peripheral vascular disease (PVD) in the literature (Bordeaux, Reish, & Hirsch, 2003).

Theoretical Framework
Milio's (1976) framework for prevention provided the theoretical background for
this study. Milio's strategies encompass concepts of health promotion and disease
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prevention central to primary care, advanced nursing practice and underserved
populations. Basically, Milio believed that the health status of individuals largely
depends on the appropriateness and availability (excess or deprivation) ofhealthpromoting resources. Healthy behavior patterns result from an individual's personal
values and available resources, either actual or perceived. Additionally, institutional
behaviors by governmental, corporate and policy making organizations dictate
"available" options for individuals. Consistent provision and accessibility of healthgenerating behaviors instead of those that are health-damaging allow for individual
assimilation. Education programs and related counseling promote health through
personal, social and cultural changes. In other words, those raised to seek health care
through the emergency department (ED) are less likely to integrate the philosophies of
health promotion and disease prevention. If health care resources were accessible and
available, then ED visits would diminish.
Success in healthcare delivery and outcomes for underserved populations require
utilization of appropriate, timely, and culturally-sensitive healthcare and education
including referral to social services and community based primary care services (Politzer,
Schempf, Starfield, & Shi, 2003). Culturally sensitive education is an important measure
necessary to facilitate positive personal values for health-generating behaviors (Milio,
1976). Underserved populations, such as the participants in this study, infrequently if
ever receive comprehensive management of their healthcare needs. The provision of
acute and chronic disease management must be augmented with appropriate screening
and education for encouragement of health-generating behaviors
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Nurse practitioners often provide community based primary care to a variety of
populations such as the elderly, school health and disabled. Those nurse practitioners
delivering care to the poor, homeless and underserved must be cognizant that these
populations have an increased mortality and morbidity (Politzer et al.) and that living in
low income and disadvantaged neighborhoods increases cardiovascular disease risk
(Sowers, Ferdinand, Bakris, & Douglas, 2002). Primary care nurse practitioners are
educated and trained to offer expansive preventive services to those at risk for vascular
diseases and it is imperative that PAD is not overlooked patiicularly in a high risk,
underserved population.
Summary

This chapter provided a brief introduction to PAD and the implications for
screening a high risk, underserved population. The significance of PAD risk assessment
and utilization of the Doppler ABI screening tool for the primary care provider were
examined followed by a description of the study's purpose, variables and theoretical
framework. A review of the literature is highlighted in chapter two, which will examine
peripheral arterial disease progression in greater detail and analyze recent clinical study
results.
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CHAPTER TWO
REVIEW OF LITERATURE
Peripheral arterial disease is a vascular disorder affecting eight to twelve million
Americans and causes significant morbidity and mortality (American Heart Association,
n.d.). Those with the disease have a fivefold increased risk of death from heart attack or
stroke. Vascular Disease Foundation president Alan Hirsch, MD has pioneered a national
PAD awareness campaign due to its association with significant detrimental effect on
functional status, quality oflife and amputation risk (Hirsch et al. 2004). The disease is of
significant importance to primary care practitioners because PAD is markedly underdiagnosed and under-treated (Norman, Eikelboom & Hankey, 2004). High risk,
underserved populations, with limited access to appropriate health screenings or
therapeutic interventions often present with multiple complications that contribute to
PAD, a manifestation of systemic atherosclerosis.
Most patients with PAD are asymptomatic but their risk of cardiovascular events
and death is equal to that of patients with symptomatic disease (Khunti, 2003). Diehm et
al. (2004) acknowledge that PAD prevalence data in primary care is limited despite its
vital impmiance to improved treatment outcomes. These researchers call for the
development of enhanced secondary prevention strategies of cardiovascular and
cerebrovascular events in the community. Effective screening for PAD in all primary
care settings may increase the chance of early diagnosis and treatment. Currently,
asymptomatic screening for PAD is not recommended (USPSTF, 2005).
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This review of the literature will examine the pathophysiology, signs and
symptoms, risk factors and disease progression. In addition, screening and diagnostic
methods, diversity issues and recent research findings are provided which represent the
state of science in PAD.
Pathophysiology ofPAD
Atherosclerosis is the most common cause of PAD (Lewis, 2001, Sieggreen &
Kline, 2004). Atherosclerosis, which begins as an insidious process, actually accounts for
approximately 90% of arterial extremity pathology (Cimminiello, 2002). Endothelial
cells lining the arterial walls may become injured through many factors including:
smoking; diabetes; hypertension and dyslipidemia. The degenerative inflammatory
process known as atherosclerosis begins as endothelial injury with progression of a fatty
streak and then a fibrotic plaque which adheres to the lining and obstructs peripheral
blood flow. Oxidized low density lipoproteins (LDL) engulfed by macrophages form
foam cells known to be destructive to the lining of the intima. Fatty streaks are the
accumulation of numerous foam cells. Fibromuscular lesions develop when collagen and
smooth muscle proliferation migrate over the fatty streak leaving a fibrotic plaque that
destroys underlying tissue. The process further decreases arterial lumen diameter and
impedes oxygenation and organ perfusion. The sequelae of this course may lead to tissue
necrosis and rupture ofthe vessel (Lewis, 2001; McCance & Huether, 2002).
Narrowing and hardening of the vessel caused by atherosclerosis leads to an
inadequate blood supply in the peripheral arteries. Exercise creates increased demand for
oxygen. Insufficient perfusion to the vasculature creates an anaerobic state which causes
the muscles to produce lactic acid (Meru et al., 2005). The resultant cramping and pain is
known as intermittent claudication, which usually occurs with an ABI between 0.30-0.90
(DeSanctis, 2001 ).
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Signs and Symptoms

It is estimated that approximately 75% ofPAD patients are asymptomatic. Since
PAD is often found with advanced age or in combination with other diseases, the patient
and provider may attribute progressive lower extremity discomfort, reduced sensation
and limited ambulation to the aging process. Asymptomatic PAD has been associated
with reduced quality oflife and impaired lower extremity functioning including; slower
walking velocity, poor balance, shorter walking distances and impaired ability to
repeatedly rise from a sitting position (McDermott, Fried, Simonsick, Ling, & Guralnik,
2000). Without diagnosis or therapeutic intervention, development of a more advanced,
painful stage may ensue.
Intermittent claudication. The most common presentation of symptomatic PAD is
intermittent claudication (IC), typically manifested by aching pain, weakness, numbness
or fatigue in lower extremity muscle groups (Bick, 2003; Schainfeld, 2001).
Acute claudication. Symptoms of IC initially occur during exertion and disappear during
rest (Cassady, 2004; Cimminiello, 2002). At this stage, the patient may walk a shorter
distance at a slower pace and experience discomfort. Diminished or absent pulses, low
skin temperature, hair loss and poor capillary refill may also be present (Goodal, 2000).
As the severity increases, symptoms of claudication may become debilitating reducing
functional ability, quality oflife and altering body image. This may cause a significant
emotional and fiscal burden to the patient, family and community.
Critical limb ischemia. Critical limb ischemia (CLI) exists when the patient experiences
pain at rest, exacerbated by the supine position. Relief may only be possible by placing
the legs in a dependent position, such as dangling over the side of the bed. At this stage,
non-healing wounds, lesions, ulcers and gangrene, which are limb-threatening
complications of PAD, (Sheehan et al. 2003) may result, requiring revascularization
surgery or amputation (Burns, Gough, & Bradbury, 2003).
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Insufficient perfusion to the extremities develops due to acute obstruction or is the
result of progressive chronic occlusion of the peripheral vasculature. Clinical
manifestations of PAD may not be realized for decades, although the detrimental effect
continues. Aging, toxins and comorbidities adversely affect the smooth intimal lining
found in otherwise healthy arteries increasing the risk of developing PAD.

Risk Factors
Diabetes. PAD is a major factor in lower extremity amputation, especially among
diabetics (Sheehan et. al., 2003). Diabetics and smokers are at risk for developing
peripheral neuropathy with resultant impaired sensory perception (Sheehan et al).
Damaged sensorineural receptors impair responses to pain and injury. Peripheral
neuropathy often complicates the discovery of PAD (Mitka, 2004). Undiagnosed and
uncontrolled diabetics are at an increased risk of developing the complications of
physical walking limitations and a reduced quality of life (Olea & Sanders, 2005).
Further, HgbAlC levels 2:5.3% are associated with higher risk of PAD (Muntner, et. al.,
2005). Diabetics have a 2-4 fold increased risk of developing PAD (NHLBI, 2003). The
American Diabetes Association (ADA) Consensus Panel suggests that patients 2:50 years
of age with diabetes and 2:40 years of age with diabetes and additional cardiovascular
disease risks should be screened using the ABI (Sheehan et al.) annually since
atherosclerosis is known to occur earlier in diabetic patients, causing reduced functioning
of the lower extremities (Dolan et al., 2002; Gordon, 2004).

Hypercholesterolemia. Hypercholesterolemia is present in approximately 40% of patients
with PAD (Stiihlinger & Tsao, 2003). An increased level of LDL is associated with the
progression of atherosclerosis which coincides with the development of endothelial
dysfunction. Arterial occlusion is the negative sequelae of chronic, untreated
atherosclerosis.

Hypertension. Fifty million Americans are affected with the nation's most common
primary diagnosis, hypertension, which also affects 50-92% of patients with PAD (Olin,
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2005). Arterioles undergo hypertrophy and hyperplasia in chronic hypertension due to
prolonged vasoconstriction and increased vascular pressure. The resultant decrease in
lumen diameter and stiffening of the vessels leads to an increased risk for PAD.
Smoldng. Valentine et al. (2004) concluded that both smokers and individuals with a
family history of CVD were more likely to develop arterial lesions. In addition to the
damage caused to the endothelial lining, smoking increases coagulation, exacerbating the
progression of atherosclerosis (Bordeaux, 2003) caused by the reduction of nitric oxide
dependent vasodilatation (Cimminiello, 2002). The incremental risk for developing PAD
in smokers is three to fivefold (NHLBI, 2003). A systematic review of the incidence and
prevalence of PAD by Willigendael et al. (2004) observed that smoking is reported by
50% of patients with disease. Their analysis also concluded that former smokers have a
2.6 fold increase in risk of asymptomatic PAD.
Disease Progression
Patients with PAD have a considerable increase in comorbidity burden (Kugler
and Rudofsky, 2003 ). Patients with intermittent claudication have a 10-year mortality rate
of 60% and report that the symptoms adversely affect their quality of life, functional
status, home-management skills, social interactions and ambulation. Though rare,
approximately 4-5% of PAD patients may have a resultant amputation (Sheehan et al.
2003). Hirsch (2003) claims that under-diagnosis of PAD in primary care hinders
secondary cardiovascular disease (CVD) prevention practices, including aggressive
treatment for diabetes, hyperlipidemia, hypertension and smoking cessation. Relevant
history taking and awareness of subtle signs are frequently overlooked in the absence of
classic symptoms of claudication (Lesho et al., 2004). Early diagnosis of PAD is of
critical importance because it is a powerful predictor of future cardiovascular events such
as myocardial infarction, cerebrovascular accidents and death (Diehm et al., 2004).
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Screening and Diagnosis
Unless specifically questioned by the primary care provider to ascertain vascular
health status, the signs and symptoms may remain undetected and the disease will be
undiagnosed and untreated (Goodal, 2000). Most ofthe risk factors for PAD are
controllable through lifestyle modification and therapeutic intervention. The most
significant modifiable risk factor is smoking (Lesho et al., 2004). Hypertension, diabetes,
hyperlipidemia, obesity and inactivity are additional examples of manageable risks. Nonmodifiable risk factors are advanced age, family history, male gender (Bordeaux et al.,
2003) and ethnicity (Collins, Petersen, & Suarez-Almazor, 2003).
At all stages along the screening and diagnostic process for PAD, the practitioner
must be cognizant of available physical and verbal assessment tools. In addition to
performing the ABI, patient education and behavior modification are essential for patient
commitment to a therapeutic regimen designed to reduce other cardiovascular and
cerebrovascular events, limb loss and death. Risk factor management is the key to
delaying the progression of PAD. Aggressive treatment of hypertension, hyperlipidemia,
diabetes and a smoking cessation program have been routinely advocated (TreatJacobson & Walsh, 2003). Routine screening in asymptomatic adults has not been
recommended by the U.S. Preventive Services Task Force (USPSTF, 2005). Saydah et al.
(2004) support the standards of medical care set by the ADA for the reduction of CVD
complications in diabetics. The ADA advocates that goals for diagnosed diabetics to be
an HgbAlc <6%, BP<l30/80, and LDL <lOOmg/dL.
Current Research Findings
Many recent PAD studies can be found in the literature. Reports by the Vascular
Disease Foundation explain the necessity for mandating the creation of a national public
awareness campaign for PAD (Hirsch et al. 2004). As is reflective of most PAD
investigations, the sample populations used in these studies are predominantly elderly
Caucasians.
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In PARTNERS, an interdisciplinary, cross-sectional PAD detection program,
investigators analyzed 6879 patients over ages 50 and older with a history of smoking or
diabetes; in 350 U.S. primary care practices. Although there was a PAD prevalence of
29% of patients diagnosed by an ABI of <0.90 with PAD, only 8.7% had IC symptoms.
Primary care utilization of IC symptoms alone for PAD diagnosis will miss more than
85% of PAD (Hirsch et al., 2001 ). Broader screening may reduce the ban-ier to effective
secondary cardiovascular disease prevention methods. Physician awareness of prior
diagnosis ofPAD was only 49%. PAD patients received less aggressive treatment than
was provided CVD patients. These researchers advised that screening with a simple ABI
measurement will identify many previously undiagnosed PAD patients and suggested that
enhanced diagnostic efforts and appropriate therapeutic interventions in primary care
practices are required to restrict critical limb ischemia, amputation and cardiovascular
risk to improve quality of life.
Researchers from the Women's Health and Aging Study (WHAS) analyzed the
prevalence of asymptomatic PAD among 1002 community dwelling, disabled women
between 65-85 years of age (McDermott et al., 2000). The authors reported the
prevalence of ABI<0.90 to be 35% ofthe target population. Also noted was that the
majority of patients with PAD did not experience exertionalleg pain, but lower ABI
levels were related to progressively poorer functioning of the lower extremities
(McDermott et al.). The General Internal Medicine (GIM) study, conducted by the same
primary investigator focused on 382 men and women over 55 years of age. They found
undetected PAD in 14% of the patients and in previously diagnosed patients, only 44%
had exertionalleg symptoms. Cigarette smoking was significant in undiagnosed PAD
patients (McDermott et. al., 2001). Finally, these investigators attributed functional lower
extremity impairment to undiagnosed PAD patients and concluded that without ABI
screening, PAD is difficult to diagnose.
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The German Epidemiological Trial on Ankle Brachial Index (getABI study), was a
large-scale, cross sectional study in which investigators assessed 6,880 men and women
(mean age 72.5 years) in German general medicine practices (Diehm et al., 2004). An
analysis of ABI, physical exam, comorbidities and the WHO questionnaire on
intermittent claudication were performed to determine the prevalence and cormorbidity of
PAD. Researchers concluded that history and physical examination of a patient are
insensitive for diagnosing PAD and recommended ABI screening. Eighteen percent of
their sample population had an ABI<0.90, with a higher prevalence in men (19.8%) than
women (16.8%). The prevalence ofPAD patients with CVD, diabetes, hypertension,
hyperlipidemia and a history of smoking were also higher than in those without PAD. As
has been found in other studies, the WHO/Rose questionnaire on intermittent claudication
only confirmed 11% of the PAD patients (Leng & Fowkes, 1992).
Researchers in another study compared comorbidity and quality oflife indices of
101 symptomatic men and women (mean age 66.4) with those of 89 asymptomatic
community-dwelling elderly individuals (mean age 77.4) and 439 geriatric nursing home
residents (mean age of 84.1 ). Comorbidity indices and illness severity using the
cumulative illness rating scales (CIRS) were significantly higher in the symptomatic
PAD patient group. Additionally, quality oflife subjective health status scores worsened
with advanced stages of PAD and IC. In fact, researchers indicated the 10-year mortality
rate associated with IC might be as high as 60% (Kugler & Rudofsky, 2003).
The Atherosclerosis Risk in Communities Study (ARIC) was a prospective cohort
study identifying PAD risk factors in 15,972 patients with diabetes, ages 45-64 years.
Participants were white and black men and women represented from four communities
throughout the United States. Analysis of study participants was conducted over a 10.3
mean year period at three year intervals. Of the participants with diabetes, 238 developed
PAD. A low ABI was the only means by which PAD was detected in 110 of the
participants. The study concluded that the risk of developing PAD in diabetics was

19
increased 1.87-fold (95% CI, range 1.36-2.57). In current smokers, the risk increased to
2.27 (95% CI, range 1.57-3.26) and in participants with baseline CHD, a 1.75-fold
increased risk (95% CI, 1.18-2.60) was demonstrated (Wattanakit, K. et al., 2005).
The prevalence oflower-extremity disease in U.S. adults' 2:40 years of age
regardless of diabetic status was reported by Gregg et al. (2004) based on the 1999-2000
National Health and Nutrition Examination Survey. This study concluded that 4.5% of
participants had lower-extremity disease. PAD was twice as common in diagnosed
diabetics-9.5%, and affected the elderly, non-Hispanic blacks and Mexican Americans in
greater proportion. Each gender was represented equally in this sample of 2,873 men and
women with a mean age were 56.9 years. The population was 75% white, 9.6% black and
4.5% Hispanic. Diabetes had been diagnosed in 9.9%, hypertension in 36%; CVD in
11.5% and 53% had a history of smoking. The study concluded that their prevalence rate
of PAD, which is lower than reported by most studies, was due to the younger age of
their sample population. A call for increased assessment, prevention and CVD
management efforts were recommended (Gregg, et. al., 2004).
A study of racial diversity as it relates to the prevalence of PAD was reviewed.
Four hundred and three Caucasians, African Americans and Hispanics > 55 years of age,
residing in lower income households near four Houston primary care clinics were
screened (Collins et al., 2003). Physical assessment including an ABI, difficulty with
walking, medical history and quality of life were performed in addition to evaluation of
questionnaires concerning symptoms of IC. The prevalence of PAD in Afi·ican
Americans (22.8%) was higher than in Caucasians and Hispanics (13.5%) with a
combined total of 18% PAD in the general medical practice. Smoking (29 .9% ), diabetes
(55.2%) and hypertension (82.1 %) were all more prevalent in patients diagnosed with
versus patients without PAD. Prior PAD diagnosis was more likely in Caucasians than
African Americans or Hispanics. Asymptomatic PAD was found in 37% of the diagnosed
patients. Researchers found the San Diego Claudication Questionnaire (SDCQ) and the
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Walking Impairment Questionnaire (WIQ) individually to have low sensitivity for PAD
when compared to ABI, the gold standard for diagnosis due to the late onset of
symptoms. Quality of life scores for physical function and role limitations were
significantly lower in PAD patients. Concern for quality of life in chronic illness
prompted the authors to promote the ABI screening tool for CVD at risk patients. Collins
et al. observed that African Americans have approximately two times the prevalence of
PAD than Caucasians and Hispanics. Though little PAD research has been conducted
with diverse populations, further studies have been suggested to clarify the actual
prevalence, especially in the medically underserved.
Researchers in the Atherosclerosis Risk in Communities Study reported that the
incidence of PAD in African American women with Type 2 diabetes is 2.4 times that of
Caucasian women aged 45-64 years (Sowers et al., 2002). The prevalence of
hypertension and CVD is also reported to be substantially higher in African Americans.
Environment, diet and access to health care contribute to an earlier onset of CVD with
increased mortality rates (Sowers et al.). Additionally, the uninsured, underserved
population is less likely to seek health care until disease progression has deteriorated
significantly (Hafner-Eaton, 1993). Therefore, those who are poor should anticipate more
chronic illnesses and a decreased lifespan (Politzer et al, 2003).
Though no major clinical research studies have been conducted on the association
of cocaine or crack and PAD, two patients with cocaine-induced peripheral vascular
occlusive disease were reported in a case study by Gutierrez, England and Krupski,
(1998). One 37 year old man presented within hours of smoking crack cocaine
complaining of severe pain and numbness in both feet. Although intervention was
extensive, he eventually required bilateral below the knee amputations. The second
patient was a 22 year old female with bilateral pedal burning pain and numbness who
presented within an hour of smoking crack cocaine. As with the previous patient, both of
her feet were cold with diminished peripheral pulses. After treatment, the second patient
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suffered no long-term negative sequelae. Cocaine's effect causes intense
vasoconstriction, increased atherogenicity and dysfunctional production of relaxin factor
production in the endothelium according to these authors. Gutierrez et al. acknowledge
that cocaine-induced coronary artery vasoconstriction is well documented, but its
influence on the peripheral vasculature warrants further investigation.
Summary
Each of the PAD studies reviewed indicates a high prevalence of an undiagnosed,
asymptomatic condition often overlooked in primary care practice. The research has
focused mainly on elderly Caucasians. Though the prevalence ofPAD increases with age,
underserved populations suffer a dispropotiionate burden of chronic illness including
hypertension, diabetes and CVD. PAD, which is a systemic manifestation of
atherosclerosis, presents often with other CVD comorbidities, patiicularly in smokers.
Broader screening measures, including the gold standard ABI, have been advocated by
many experts interested in early detection of PAD in order to promote vascular health and
maintain quality oflife (Heidrich, Wenk, & Hesse, 2004). This coincides with Milio's
framework for prevention, which challenges the health care delivery system to provide
state of the art modalities and promote health-generating behaviors in underserved
populations.
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CHAPTER THREE
METHODOLOGY
The purpose of this cross sectional descriptive study was to determine the
prevalence of PAD in a high-risk, underserved predominantly African American
homeless population and to determine if an electronic blood pressure machine could
accurately measure ABI. The assessment will be done through physical examination, the
San Diego Claudication Questionnaire (SDCQ) and ABI analysis. The sample population
was largely African Americans who are at greater risk for developing cardiovascular
diseases. A comparison of hand-held Doppler blood pressure readings versus the use of
an electronic blood pressure machine for ABI assessment was conducted. The review of
literature indicated that the prevalence of PAD is as much as 29% (Hirsch et al., 2001) in
the primary care setting. Hypertension, hyperlipidemia, diabetes and cigarette smoking
compound the risk for PAD, cardiovascular disease and cerebrovascular events. As has
been documented, PAD is underdiagnosed and undertreated in the primary care setting.
Given that the majority of patients are asymptomatic or have atypical presentations,
secondary prevention strategies are limited. Evaluation of diabetics for PAD may be
more difficult due to decreased sensory perception from peripheral neuropathy and distal
vessel lesions, though the incidence of PAD in diabetics is more prevalent than in
nondiabetics. Reduction of dyslipidemia and hypertension are advised to reduce the risk
of claudication and to promote cardiovascular health. The most important modifiable
cardiovascular risk factor is smoking. Tobacco use is highly associated with the
development and exacerbation of PAD. Smoking is also linked to the progression of
atherosclerosis and an increased amputation risk (Sheehan et al., 2003). This chapter will
discuss the methodology used in this study.
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Sample
A nonprobability convenience sample of patients at a local shelter was used.
Confirmed diagnoses of diabetes, hypertension, hyperlipidemia or history of cigarette or
crack cocaine smoking, regardless of age, were the inclusion criteria. A confirmed
diagnosis was assumed if documentation in the participant's chart was established and/or
the patient was receiving medication for diabetes, hypertension or hyperlipidemia.
Additionally, laboratory or diagnostic values were considered evidence of disease
for inclusion criteria in the following instances. Hypertension was assumed if the patient
had two or more systolic blood pressures of> 129 or a diastolic blood pressure of >80
(Ebell, 2004). History of smoking was established by patient confirmation of prior usage
and a years used or pack year value was determined. Hyperlipidemia was assumed if
LDL values were> 100 and/or total cholesterol was >200. Fasting blood glucose (fbg)
over 126 was diagnostic of diabetes.
The target population was predominantly African American, previously homeless,
indigent, many with substance abuse histories and limited access to sufficient,
appropriate health care, health promotion or disease prevention programs. This group is
reflective of the high-risk underserved population in northeast Florida. Available patients,
who met the study criteria and gave their consent for participation, represented the
sample population

Setting
The setting was the medical clinic at a local shelter which is a faith-based, recovery
residence for the homeless and needy in Northeast Florida. In addition to medical care,
residents were provided with counseling, education or vocational training and Bible
study. The clinic had three patient examination rooms, a nurse's assessment station, a
pharmacy and a front office. The facility was adequately equipped to accommodate the
proposed study.
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Data Collection
The primary investigator conducted all steps of the procedure unless otherwise
noted. Review of current patient charts and new patient initial assessments identified the
potential sample. Based on inclusion criteria, patients were asked to participate in the
study through direct contact by the researcher. The study purpose and procedures were
explained and a written consent to participate was obtained (see Appendices A and B).
Once consent was obtained, participants were given an appointment for testing. A
physical assessment, patient history and San Diego Claudication Questionnaire results
were collected and documented. An ABI assessment was obtained on every participant.
The systolic blood pressures from bilateral brachial arteries and from either the dorsalis
pedis or posterior tibialis of both ankles were recorded. The ABI Doppler assessment and
electronic blood pressure measurements were assessed by the primary investigator, a
skilled practitioner, using the standard procedure (See Table 3.1). Interpretation of ABI
ratio readings is presented Table 3.2. Each participant with an ABI:S0.9 was referred to
the medical clinic director and/or a vascular specialist for further evaluation.
Table 3.1

ABI Measurement Procedure

Step 1
Step 2

Rest patient in supine position for five minutes
Bilateral brachial systolic BP taken at antecubital fossa using stethoscope
and BP cuff, the higher reading will be used to calculate ABI
Place appropriate size cuff around right ankle
Obtain BP using Doppler at dorsalis pedis or posterior tibialis arteries
Repeat step with left ankle
ABI is calculated by dividing the higher ankle systolic BP for each leg
By the highest brachial systolic BP, record results
Repeat procedure using the EBM, record results

Step 3

Step 4
Step 5

(Sheehan et al. 2003; Weber & Kelley, 2003)
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Table 3.2
ABI
ABI
ABI
ABI
ABI
ABI
ABI

ABI Interpretation Results

0.91 to 1.30
::=:;0.90
>0.80 to ::=:;0.90
0.50 to 0.80
<0.50
<0.25
>1.30

Normal
Abnormal
Mild disease, possibly asymptomatic
Moderate disease
Indicative of severe occlusive disease
Typically indicative of ischemic rest pain or tissue loss
Poorly compressible arteries from calcification in diabetes

(Sheehan et al., 2003)
Instruments
Two written instruments were used for this study, a data collection form was
developed by the primary investigator (see Appendix A) and the San Diego Claudication
Questionnaire (SDCQ) (see Appendix B). The data collection form reflected pertinent
diagnoses, physical assessments and clinical impressions. The SDCQ, developed by
Michael Criqui, MD, is based on the WHO/Rose intermittent claudication questionnaire
and has documented reliability and validity (Criqui et al., 1996). The difference between
the SDCQ and the WHO/Rose questionnaire is that the SDCQ is able to provide an
evaluation for bilateral results. The questionnaire was administered verbally or given as a
self-test, to assess if each patient had no pain, was asymptomatic, had symptomatic PAD
or intermittent claudication, which is also identified in the literature as Rose or typical
claudication. The SDCQ is an enhanced version of the widely used WHO/Rose
intermittent claudication questionnaire developed in 1962 by Leng and Fowkes (1992).
Studies have shown the WHO/Rose questionnaire to have a sensitive of 60-68% and a
specificity of90-100% (Cimiminiello, 2002). The SDCQ incorporates revisions made on
the WHO/Rose questionnaire to include the evaluation of buttock, thigh and right or left
leg specific symptoms. Permission for the SDCQ use was provided by Dr. Criqui (see
Appendix C).
Ankle-brachial index, the ratio of the ankle systolic pressure to the brachial systolic
pressure was ascertained. This objective test measures the lower extremity arterial
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perfusion (DeSanctis, 2001). It has 91.3% sensitivity and 99.3% specificity (Leng &
Fowkes, 1992). Instruments used to obtain the brachial and ankle blood pressures were a
hand-held 5-10 MHz Doppler and an EBM. The Welch-Allyn Propaq 102 EL vital signs
monitor was the EBM used in this study. The hand-held ultrasound Doppler used for this
study was the Nicolet Vascular Elite model #100 with an 8MHz probe. Both instruments
have been inspected for accuracy and reliability to conform to American Standards for
Testing Materials (ASTM) guidelines.
Statistical Analysis
A descriptive statistical analysis was conducted to evaluate the data utilizing SPSS
v 14.0 software. The level of data collected and the anticipated findings are provided (See
Table 3.3) including research questions and the demographic data.
Protection ofHuman Subjects
The Institutional Review Board (IRB) of the University ofNorth Florida approved
the design and intent of this study for the protection ofhuman subjects. Each subject,
prior to participati?n in the study, completed an informed consent document (see
Appendix D). The right to refusal from participation in the study without penalty was
offered to each study participant as was the option to discontinue participation at any
point.
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CHAPTER FOUR
RESULTS
The purpose of this study was to describe the prevalence of PAD in an
underserved, high-risk, predominantly African American, homeless population and to
determine if the electronic blood pressure machine (EBM) could accurately measure ABI
compared to findings obtained by Doppler technique. Over a period of fifteen months,
medical clinic patients were evaluated and 56 were enrolled in the study based on
eligibility criteria. Due to the transient nature of the shelter, 16 enrollees were unavailable
at the time the clinical data were gathered. The total sample size, therefore, was 40.
Demographic Data
The study was conducted at the medical clinic of a residential shelter for the
homeless. The average age of the sample was 46.03 years (range =20-59 SD = 9.09). The
sample population was 70% male (n=28). Twenty-seven (67.5%) were Black, 12 (30%)
were White, and 1 (2.5%) was Hispanic. The mean BMI of the 38 patients for whom
these data were available was 29.78 (range= 20.64 to 64.7, SD 8.22).
Figure 4.1 Descriptive statistics
Gender (n=40)
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Figure 4.2 Descriptive statistics
Race (n=40)

~25r---------------GI

'.0 20

r:.

+--------------

r--------,--j -x>r----

0

e

i

15

a White 30%

aBiack67.5%
D Hispanic 2.5%

5+----0+-----

Risk Factors
Hypertension, diabetes, hypercholesterolemia and a history of smoking are the
comorbidities of cardiovascular disease which were identified and utilized as the
eligibility criteria (See Table 4.3).
Hypertension. Of the study participants 55% (n=22) had a diagnosis of hypertension.
Twenty of these (90.91 %) were on antihypertensive medications. Ten ofthose patients
were on two antihypertensive medications and two patients were on three
antihypertensive medications. Of the 22 patients on reported antihypertensive
medications, only six had a systolic blood pressure under 120mmHg and a diastolic blood
pressure below 90mmHg.
Hypercholesterolemia. Forty-two percent (n=17) of the sample population had a
diagnosis ofhypercholesterolemia. Eleven of these (64.71 %) were on antilipidemic
medications. The serum cholesterol readings revealed that four patients had a total
cholesterol level under 200mg/dl and five patients had a low density lipoprotein level
below 100.
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Diabetes. Twelve patients (30%) had a diagnosis of diabetes. All twelve patients were on

either oral glucose lowering medications or insulin. Only two patients however, had an
HgbA1 C under 6.0% or fasting blood glucose under 1OOmg/dl.
Smoldng. Eighty percent (n=32) had a history of cigarette smoking prior to their residence

at the shelter. A prior habit of smoking crack cocaine was reported by 85% (n=34).
Table 4.3 Risk Factor Analysis
Number Percent
Risk factor
40
100
Age
BMI
40
100
22
Hypertension
55
Systolic BP
Diastolic BP
Hyperlipidemia
17
42
Total
LDL
12
Diabetes
30
Fasting glucose
HgbA1C
Smoking
Cigarette-pk yrs
32
80
Crack yrs of use
34
85

Minimum Maximum Mean
20
59
46.03
20.64
64.70 29.78

Std Dev N
40
9.09
8.22
38

102
64

194
110

140.45
87.45

22.85
11.35

22
22

153
58

298
189

215.19
124.70

42.08
40.91

16
15

89
5.4

401
18.10

198.67
8.27

92.83
2.68

12
12

1
0.1

80
25

26.69 18.67
9.25 7.63
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Clinical Assessment

Lower extremities were examined in all study participants with an evaluation of dorsalis
pedis and posterior tibialis pulses, pedal temperature, hair loss, capillary refill, thickened
toenails, shiny or scaly skin, lesion, ulcer or gangrene, sensory perception and edema was
assessed. Bilateral adverse assessment findings were recorded (see Figure 4.3 and Figure
4.4).
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Bilateral Extremity Assessment I

Figure 4.3
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Bilateral Extremity Assessment II

Figure 4.4
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San Diego Claudication Questionnaire. Thirty-nine of the forty participants completed
the questionnaire. Evaluation of questionnaire results using criteria provided by the
author revealed that four participants had symptoms consistent with claudication, one
participant had non-Rose calf pain, 25 participants had pain at rest, 9 pmiicipants
reported no pain and one participant did not complete the questionnaire (n=39) (See
Figure 4.5).
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Figure 4.5

San Diego Claudication Questionnaire Results
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Ankle-brachial index. The ankle-brachial index was obtained on both the right and left
extremity of each study participant using the Doppler method and the electronic blood
pressure machine. Using the standard Doppler method, a reading of ::;.90 was obtained in
the right extremity of five study participants (12.5%) and in the left extremity in six
participants (15%), for a total of22.5% ofthe sample population. Two participants had
bilateral disease. The electronic blood pressure machine indicated no study participants
with an ABI of .90 or lower. Using the Doppler, two right (5%) and two left (5%)
extremities revealed an ABI> 1.30 while the electronic blood pressure machine revealed
an ABI> 1.30 in four right (1 0%) and seven left (17.5%) extremities. This is indicative of
non-compressible vessels associated with diabetes.
Table 4.4 presents the demographic data, number of risk factors, results from the San
Diego Claudication Questionnaire (SDCQ) and bilateral ABI results using both the gold
standard hand-held Doppler and the electronic blood pressure machine for each study
participant with an ABI ::;.90.
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Table 4.4 Abnormal ABI Results (ABI:S0.90*)
SDCQ

ABI by Doppler

ABI Electronic BP

3C

Rest

R 0.900* L 1.070

R 1.090

L 1.180

37wm

1C

Claudication R 1.118

L 0.847*

R 1.190

L 1.340

4

45bm

3C

None

R 0.927

L 0.900* R 1.238

L 1.247

8

56bm

2C

None

R 0.980

L 0.740* R 0.990

L 0.915

30

45bm

4C

Rest

R 1.060

L 0 .830* R 1.230

L 1.210

31

50bm

4C

Claudication

R 0.720* L 0 .909

R 1.090

L 1.009

33

56bm

3C

None

R 0.900* L 1.010

R 1.240

L 1.130

35

54bm

2C

None

R 0.680* L 0.780* R 1.050

L 0.920

40

30wm

1C

Claudication R 0.690* L 0.845* R 1.040

L 0.970

Pt

Dem

1

48bm

3

#RF

Discussion

All of the study participants with an abnormal ABI were male. Seven of the nine
men (78%) with abnormal ABis were black and 22% (n=2) were white. The mean age of
these participants was 46.78 with a minimum age of 30 years and a maximum of 56
years. Eighty-five percent of the entire sample population had a history of crack cocaine
use, but in those with an abnormal ABI, 100% had a history ofusing crack cocaine.
Three participants, or 33% reported results consistent with claudication on the SDCQ and
only two participants, or 22% had bilateral abnormal ABis. Using the EBM, no reports of
an abnormal ABI were obtained.
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CHAPTER FIVE
CONCLUSION
The objective of this study was to identify the prevalence of PAD in residents at a
local homeless shelter and to determine the efficacy of using an electronic blood pressure
machine to accurately assess ABI. All study participants were identified to have at least
one of the risk criteria ofhypettension, hypercholesterolemia, diabetes or a history of
smoking. It is difficult to determine if this sample is generalizable to national high risk,
underserved homeless populations due to an inability to accurately gather census data,
however, the study population is reflective of the homeless population at this resident
shelter in Northeast Florida.
The importance of this study is the unique view provided professionals of an
infrequently studied population since health status analysis of the homeless is complex
and rarely reported. National disease prevalence ofP AD has been established
predominantly through studies with participants who are older, Caucasian and insured. A
29% prevalence of PAD was reported by the PARTNERS study, but it is essential to
restate that the average age ofthat sample was 70 years (Hirsch et al., 2001). The
National Health and Nutrition Examination Survey reported a lower-extremity prevalence
of 4.5% and a 9.5% respectively in diabetics and non-diabetics (Gregg, et. al., 2004). The
prevalence oflower-extremity PAD, indicated by an ABI:S0.90 in this sample, with a
mean age of 46.03 years was 22.5% at this local resident shelter in Northeast Florida.
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This significance of this finding is reflective of the sample population which is
70% male, 70% non-white and 100% homeless. None of the participants had medical
coverage or consistent healthcare. The cardiovascular and cerebrovascular risks suffered
by the participants in the study were hypertension-55%, hypercholesterolemia-42% and
30% diabetes. A striking 80% had a history of smoking cigarettes and 85% had a history
of smoking crack cocaine.
The use of the electronic blood pressure machine indicated that no study
participants had an ABI:S0.90. Furthermore, it is important to reiterate that all study
participants were evaluated using both the Doppler and electronic blood pressure
machine. The electronic blood pressure machine was found in this study to be an
insensitive tool in identifying PAD using the ABI method.
Limitations
The small sample population and the extended period of time that the data was
gathered combined with the transient nature of the shelter population limited the ability to
achieve exact point prevalence. A probability sample was not possible for this study since
the identity and location of all high-risk underserved individuals in northeast Florida is
unknown, which is a limitation of the study. Some data were not available when the
results were tallied and 16 people whom had given their consent were no longer available
for further investigation at the time the study was conducted. Four individuals, who met
the criteria, declined participation. The study excluded individuals without the known
CVD risk factors of hypertension, hypercholesterolemia, diabetes or a history of smoking
potentially resulting in altering the identified prevalence of PAD. The participants were
required to refrain from smoking once they entered the residence which may improve
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their ABI. Also, no documentation of duration since diagnosis of risk factors or length of
treatment was evaluated and no documentation on various test results (e.g. blood
pressure, HgbalC, LDL) was gathered unless the pmiicipant had a diagnosis of the
specific comorbidity. Most study patiicipants completed their own SDCQ allowing for
the introduction of error due to interpretation. An interviewer administered questionnaire
was offered to every participant.

Implications for Further Study
The results of this study clearly indicate the importance of further research in the
investigation of PAD on a larger scale in an underserved, high risk population. Special
attention should be given to the high risk population who are currently smoking and using
illicit drugs on a regular basis. The prevalence of PAD in those without known risk
factors is of interest since many who are homeless and underserved are unaware that they
have certain diseases known to predispose them to PAD.

Conclusion
In conclusion, the appearance of risk factors in an underserved high risk
population identifies a significant percentage of individuals with peripheral arterial
disease. The prevalence of 22.5% is higher than nationally reported given the average age
of 46.03 years in this study. The sample population is much younger than currently
studied and available in the literature for this disease process. Unlike all published studies
on peripheral arterial disease, little data is known about the correlation ofunderserved
populations and illicit drug use and the prevalence of PAD. Screening those at risk for
PAD using the Doppler ABI assessment technique is non-invasive, inexpensive and well
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tolerated. It is an impmiant tool which can be utilized to reduce the risk of CVD and
amputations and maintain quality of life.
Primary care nurse practitioners, providing services in the community to an
underserved population, may have limited time and resources for adequate assessment
and therapeutic intervention. Secondary and tertiary prevention strategies based on
patient needs must incorporate education and health-promotion relative to the
individual's personal values, according to Milio's framework (1976). Furthermore, the
nurse practitioner must advocate for corporate and governmental policies that promote
health and resources for all citizens.

37

Patient's initials:

APPENDIX A
DATA COLLECTION FORM
DOB:
Sex:

HTNDx:

BP:

HLIPID Dx:

Tchol:

Ldl:

Hlipid Med:

DMDx:

Fbg:

HgbAlc:

DMMed:

Smoker:

Race:

BPMed:

Pacldyear history

PHYSICAL ASSESSMENT (Document presence/absence/charactenstlC)
Right foot/leg

Assessment Criteria
Posterior tibialis pulse

Left foot/leg

Dorsalis pedis pulse
Low skin temperature
Hair loss
Capillary refill
Thickened toenails
Shiny/scaly skin
Lesion/ulcer/ gangrene
Sensmy perception
Edema
ABI CALCULATION

Doppler

Brachial systolic:

Right:

Left:

Dorsalis Pedis:

R:

L:

Posterior Tibialis:

R:

L:

Electronic BP
R:

L:

ABI:

R:

L:

ABI:

ABI:

R:

L:

ABI:

Take highest ankle systolic per leg/highest of both brachial systolic= ABI Ratio
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APPENDIXB
SAN DIEGO CLAUDICATION QUESTIONNAIRE
(INTERVIEWER ADMINISTERED VERSION)
Right
1) Do you get pain or discomfort in either leg or either

Left

1

No

1

buttock on walldng?
Yes

2

2

(If no, stop)

1

1

2

2

1

1

2

2

1

1

2

2

1

1

2

2

1

1

2

2

Never walks uphill/hurries

3

1

1

2

2

2) Does this pain ever begin when you are standing still
or sitting?

No

Yes

3) In what part of the leg or buttock do you feel it?

No

a) Pain includes calf/calves

Yes

b) Pain includes thigh/thighs

No
Yes

c) Pain includes buttoclv'buttocks

No
Yes

4) Do you get it when you walk uphill or hurry?

No
Yes

5) Do you get it when you walk at an ordinary pace

on the level?

No
Yes
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1

1

2

2

Stop or slow down 1

1

Continue on

2

2

Lessened or relieved

1

1

Unchanged

2

2

10 minutes or less

1

1

More than 10 minutes

2

2

6) Does the pain ever disappear while you are walking?

No
Yes

7) What do you do if you get it when you are walking?

8) What happens to it if you stand still?
(If unchanged, stop)

9) How soon?

Answer Key
1) No pain- 1=1
2)

Pain at rest-1=2 and 2=2

3) Non-calf-1=2 and 2=1 and 3a=1 and 3b=2 or 3c=2
4)

Non-Rose calf-1=2 and 2=1 and 3a=2, and not Rose

5) Rose-1=2 and 2=1 and 3a=2 and 4=2 or 3 (and if 4=3, then 5=2)
And 6=1 and 7=1 and 8=1 and 9=1
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APPENDIXC
AUTHORIZATION FOR USAGE OF SAN DIEGO CLAUDICATION
QUESTIONNAIRE

Dr. Criqui,
I read with interest several articles you authored or co-authored on PAD. I am a
nurse practitioner candidate at the University of North Florida and would like to
possibly use the San Diego claudication questionnaire for a study which I will
shortly begin. Will you please advise me how to get access and permission to use
the questionnaire in my study? Thank you in advance for your help.
Laura M. Triola, MAS, RN

Hi Laura, Both interviewer and self administered versions attached. Feel free to use. MC
Michael H. Criqui MD, MPH
Professor and Vice-Chair
Dept. ofFamily and Preventive Medicine
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Appendix D

UNIVERSITY OF NORTH FLORIDA
JACKSONVILLE, FLORIDA
HUMAN RESEARCH CONSENT FORM
TITLE: Peripheral arterial disease screening of a high-risk underserved population
INVESTIGATORS: Laura Triola, RN
AFFILIATIONS: University ofNorth Florida School ofNursing
CONTACT INFORMATION: Laura Triola, RN
1209 Salt Creek Island Drive
Ponte Vedra FL 32082 904-273-1279
Deloris Irvin
School ofNursing
904-620-2680
APPROVED BY INSTITUTIONAL REVIEW BOARD:
This is an important form. Please read carefully. It tells you what you need to know about
this research study. If you agree to take part in this study, you need to sign this form.
Your signature means that you have been told about the study and what the risks are.
Your signature on this form also means that you want to take part in this study.
Your participation in this research is entirely voluntary. Refusal to participate in this
research will involve no penalty or loss ofbenefits to which you otherwise are entitled.
You may discontinue participation in this research study at any time without penalty or
loss ofbenefits you are otherwise entitled to.
What is the purpose of this study?

The purpose of this study is to determine the amount of Peripheral Arterial Disease
(PAD) or severe leg problems, at this clinic.
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How many participants will take part in this study?

We hope to enroll thirty-five to fitfy participants will participate in this study.
What will happen in this study?
If you are able and choose to be in this study, your medical records will be reviewed

to see if you have high blood pressure, high cholesterol, diabetes and history of
smoking. You will be asked to answer some questions about your legs and if you
have any pain when you walk or exercise. A brief examination of your legs and feet
will be performed. Blood pressure readings in your arms and legs will be taken
using two machines. An ankle-brachial index will be calculated from the blood
pressure readings and will help determine your risk of PAD (severe leg problems).
How long will I be in the study?

The procedure described above will take approximately one hour and will be
conducted over the next eighteen months to two years.
Are there reasons I might leave the study early?

Taldng part in this study is your decision. You may decide to stop at any time. You
should tell me if you wish to stop participation in the study or you may be asked to
discontinue participation if it is in your best interest to do so.
What are the risks of the study?

There are no apparent risks to participation in this study. Some discomfort may
occur while you are lying flat or when the blood pressure cuff is inflated (pumped
up).
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What happens if I am injured because I took part in this study?

No physical or emotional injuries are anticipated
(If more than minimal risk, will I be compensated if injured? Will medical treatment be
provided? If so, what will it consist of? Where can I get further information on this
matter?)
N/A
Are there benefits to taking part in this study?

Because this is a screening test, the results may indicate that you have a potential
problem with circulation (blood flow) in your legs. If that happens, we will help you
get an appointment for follow-up treatment.
What other choices do I have if I do not take part in this study?

You may continue to receive your regular medical care.
Are there any monetary or other compensation or inducements for my taking part in this
subject?

None.
Are there any financial costs to me to take pmi in this study?
If you are referred to medical care for follow-up based on the screening, that care

will be paid the same way as if you were not participating in the study.
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What are my rights if I take part in this study?

You do not have to take part in this study; but if you do, you can stop at any time.
You will be told of important new findings or any changes in the study or
procedures that may affect you. You do not give up any of your rights by taldng
part in this study.
What about confidentiality?

Data from this study may be published or used in publications. However, your name
and other identifying information will not be sent outside of UNF without written
permission unless the law allows it.
EXPLAIN YOUR METHOD FURTHER
The ankle-brachial index involves using a blood pressure cuff and special
stethescope to take your blood pressure in each arm and each ankle. From this a
number is calculated indicating your risk for PAD (severe leg problems).
Will there be audiotaping or videotaping? If so, will I get to view them before they are
used? Who will review tapes besides the researchers? Who will have access to the tapes?
When will they be destroyed?
(Note- If tapes are to be used outside of the research project, a separate release form
should be obtained.)

No videotaping or audiotaping will be included in this study.
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Who can answer my questions?

You may talk to Laura Triola, RN at any time about questions and concerns you
may have about this study. You may contact Laura Triola, RN at the University of
North Florida School of Nursing, (904) 620-2685. You may also call Dr. Jan Meires,
faculty mentor at 620-1469.

You may get further information about UNF policies, the conduct of this study, the
rights of research subjects or if you suffer injury related to your participation in this
research project from the Institutional Review Board Chairperson, Dr. Kathaleen
Bloom, at (904) 620-2685.
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I have had an opportunity to have my questions answered. I have been given a copy of
this form. I agree to take part in this study. I am over 18 years of age.
I am at least 18 years old. _ _ _ _ (initials)
I have had the study that I am agreeing to participate in explained to me to my
satisfaction. _ _ _ (initials)
I have had the opportunity to ask any questions that I may have had regarding this study.
_ _ _ _ _ (initials)
I agree to participate in (study name) Peripheral arterial disease study
conducted by (PI)

Date

_....;:L::..:a::..:u;:;.:r-=a'-'T::;...:r:...:;io.;;;..:l:.::a""',RN=.:........-

being

and the University of North Florida.

Printed Name ofParticipant

Signed Name ofParticipant

Date

Printed N arne of Individual Obtaining Consent

Date

Signed Name oflndividual Obtaining Consent
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APPENDIXE
Consent to Participate in Research Script
You have been asked to participate in a study.
Purpose: The purpose of this study is to find out how many residents have severe leg
problems or peripheral arterial disease (PAD).
Duration: The study will be conducted over an 18-month period. You will be asked to
undergo a physical exam and answer a questionnaire that will take about two hours of
your time.
Procedure: If you agree to participate, you will:
1) Be asked questions about your health.
2) Have a physical exam taken of you legs and feet.
3) Answer a nine-item questionnaire.
4) Have blood pressure readings taken of your arms and legs using two
different machines.
Eligibility: A resident is able to participate if he or she has any of the following
conditions.
1)
2)
3)
4)

High blood pressure (hypertension)
High blood sugar (diabetes)
High blood fats (hyperlipidemia)
History of smoking

We hope to enroll 35-50 participants in this study.
Risks: There are no known risks to participation in this study.
Benefits: This screening tool will help to identify a severe leg problem.
Alternative Care: Participation in this study is totally voluntary. If you decide not to
participate in this study you will continue to receive care at the medical clinic as you did
previously.
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Confidentiality: All records will be kept confidential. No publications will contain
specific patient information. Your identity will not be disclosed.
If you have any questions or concerns, please contact me, Laura Triola, RN at 904-2731279 or Dr. Jan Meires at the University ofNorth Florida 904-620-1469.
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